Allergan Bolsters Botox Biz With Medy-Tox Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma is highly protective of its slot as the market leader in neuro modulators and has been working to add indications, as well as conduct deals that can help it retain its position with its Botox franchise.